Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Belzutifan with Lenvatinib in Patients with Advanced Renal Cell Carcinoma	Belzutifan (PT2977; MK-6482) , Lenvatinib (Kisplyx; E7080; lenvatinib mesilate)	Renal cell carcinoma (RCC)	Renal Cancer	2024	View \| Download
Belzutifan for von Hippel-Lindau disease-associated clear cell renal cell carcinoma – first line	Belzutifan (PT2977; MK-6482)	Renal cell carcinoma (RCC)	Genetic Disorders , Oncology , Renal Cancer	2021	View \| Download
Belzutifan for advanced or metastatic clear cell renal cell carcinoma after 1 therapy	Belzutifan (PT2977; MK-6482)	Renal cell carcinoma (RCC)	Renal Cancer	2022	View \| Download
Belumosudil for graft versus host disease	Belumosudil (SLx-2119; KD025; KD-025)	Graft versus host disease (GvHD)	Immunology	2021	View \| Download
Belinostat (Beleodaq) with CHOP for treatment of patients with peripheral T‐cell lymphoma, 1st line	Belinostat (Beleodaq; PXD101) , CHOP	Peripheral T-cell lymphoma (PTCL)	Haematological Cancer and Lymphomas	2017	View \| Download
Belimumab in combination with rituximab for systemic lupus erythematosus (SLE)	Belimumab (Benlysta; Lymphostat-B) , Rituximab (MabThera; Rituxan; RG 105)	Systemic lupus erythematosus (SLE)	Immunology , Nephrology	2021	View \| Download
Belimumab for lupus nephritis	Belimumab (Benlysta; Lymphostat-B)	Lupus nephritis	Immunology , Nephrology	2019	View \| Download
Belimumab (subcutaneous injection) add-on for systemic lupus erythematosus in children aged 5 to 17 years old	Belimumab (Benlysta; Lymphostat-B)	Systemic lupus erythematosus (SLE)	Immunology , Nephrology	2022	View \| Download
Belantamab mafodotin with pomalidomide and dexamethasone for previously treated relapsed/refractory multiple myeloma	Belantamab mafodotin (GSK2857916; anti-BCMA-ADC) , Dexamethasone (dexamethasone sodium metasulfobenzoate) , Pomalidomide (Imnovid; CC-4047; Pomalyst)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download
Belantamab mafodotin with bortezomib and dexamethasone for previously treated relapsed/refractory multiple myeloma	Belantamab mafodotin (GSK2857916; anti-BCMA-ADC) , Bortezomib (Velcade; bortezomib mannitol boronic ester) , Dexamethasone (dexamethasone sodium metasulfobenzoate)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download